To further determine the regulatory role of ERK1/2 and p38 signaling in controlling citrate‐induced suppression and senescence in tumor cells, we utilized the specific pharmacological inhibitors U0126 (ERK1/2 inhibitor) and SB203580 (p38 inhibitor) to block MAPK signaling in tumor cells. This evidence concerns the gene MAPK3 and neoplasm.